Is Rosehip Osteoarthritis Meta-Analysis safe?

The current Migaku evidence database contains 2 reusable source documents for Rosehip Osteoarthritis Meta-Analysis. This answer focuses on safety, limits, and clinician-discussion contexts. - It causes chronic pain, reduced mobility, and disability, affecting 607 million individuals worldwide, with nearly 46.6 million new cases annually []. [Muacevic Alexander (2026); evidence level 4] - 11 12 13 14 15 11 15 HLA-DRB1 HLA-DQB1 Genetic polymorphisms in sterol regulatory element-binding protein 2 (rs2228314) [], interleukin-6 (rs1800795) [], and resistin (RETN) [] in Indian and Pakistani cohorts and growth differentiation factor 5 (rs143383) [],, andin Thai populations [] are linked to OA risk. [Muacevic Alexander (2026); evidence level 4] - Need for expert opinion Despite growing clinical and mechanistic evidence for collagen supplementation in OA, several gaps and challenges remain in translating this knowledge into clinical practice, especially in the Indian subcontinent and Southeast Asia. [Muacevic Alexander (2026); evidence level 4] - 1 2 3 4 6 7 8 9 10 1 Osteoarthritis (OA) is the most prevalent degenerative joint disease globally and the second most common rheumatologic condition []. [Muacevic Alexander (2026); evidence level 4] - 1 2 [3] [4] [5] Physical activity and pharmacological treatment are both well-established, evidence-based interventions for managing osteoarthritis (OA)-related symptoms. [Dahlberg Leif E. (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.